Pharmacy Medical News about Warfarin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
Annals of Pharmacotherapy, 10/13/09

Cheetham TC et al. – In general, nonselective NSAIDs and selective COX–2 inhibitors should be avoided in patients taking warfarin. In situations where patients require NSAIDs and cannot be managed using other therapies, The results suggest that selective COX–2 inhibitors are associated with fewer hospitalizations for GI bleeding.

<< Previous
Novartis enters into agreement for exclusive US and Canadian...

Next >>
Long-term Clinical Outcome of Patients with Severe Combined...

Safety of Concomitant Tamoxifen and Warfarin
Annals of Pharmacotherapy, 10/21/09 Relevance Score: 90%

Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation
Cerebrovascular Diseases, 11/12/09 Relevance Score: 89%

Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients
Clinical Medicine & Research, 10/09/09 Relevance Score: 87%

Can We Predict Daily Adherence to Warfarin? Results from the IN-RANGE Study
Chest, 11/12/09 Relevance Score: 85%

Uninterrupted Warfarin for Periprocedural Anticoagulation in Catheter Ablation of Typical Atrial Flutter: A Safe and Cost-Effective Strategy
Journal of Cardiovascular Electrophysiology, 10/06/09 Relevance Score: 85%